Putney Names Experienced Negotiator as Senior Director of Business Development
Date: June 24, 2008
Portland, Maine, June 24, 2008 — Putney, Inc., a specialty pharmaceutical company focused on development of generic drugs for companion animal veterinarians, today announced the addition of Stacey Vaughan to the management team as Senior Director of Business Development.
Ms. Vaughan will structure and negotiate deals with FDA approved and inspected manufacturers of generic drugs located in the U.S. and abroad. She will also be responsible for commercial partnerships and in-licensing agreements.
"As head of Business Development, Stacey is focused on the contracts and relationships with our alliance partners that deliver the products in our portfolio" said Jean Hoffman, president of Putney. "Our initial veterinary generic products are hitting their development and submission milestones," continued Hoffman. "Stacey can now focus on completing additional deals to expand our portfolio of generic products for companion animal veterinarians and pet owners."
Putney has one of the largest portfolios of products in companion animal medicine, spanning oral solids and liquids, palatable chews, and sterile products for dogs and cats.
Prior to joining Putney, Ms. Vaughan was Director of Business Development at Catalent Pharma Solutions (previously Cardinal Health), a leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies. She was responsible for sales and business development functions for a patented, proprietary drug delivery technology. Stacey Vaughan has more than 13 years experience in the pharmaceutical industry.
About Putney, Inc.
Putney, based in Portland, Maine, is a new pharmaceutical company focused on the development of generic drugs for pets. The company seeks to offer high quality prescribing options to veterinarians so treatment decisions can be made based on pet patient needs and so pet owners can afford to give their pets the entire course of therapy.
More information can be found at www.putneyvet.com
Contact: Christina Perkins, Vice President, Marketing & Communications
207-553-4430
christina.perkins@putneyvet.com